Endpoints News 生物医药· Ryan Cross·· 2026-10-14AI 评分36
Arrowhead Pharma 靶向脑部 RNA 药物在早期研究中降低阿尔茨海默病蛋白 tau 水平
Arrowhead’s brain-targeting RNA drug lowers Alzheimer’s protein in early study
AI 导读
Arrowhead Pharmaceuticals 的一项早期研究表明,其皮下注射的遗传学药物似乎能进入脑部并降低 tau 蛋白水平。该 tau 蛋白是阿尔茨海默病的一个生物标志物。
正文
Arrowhead Pharmaceuticals has shown that a genetic medicine administered as a subcutaneous injection can seemingly travel into the brain and lower levels of tau, a …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
来源:Endpoints News 生物医药 · endpoints.news